Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 31722-488

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 31722-488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion150mg30scount (Bupropion150mg30scount)

This text provides information about Bupropion Hydrochloride Extended-Release Tablets, USP (XL). It includes a warning not to use it in combination with ZYBAN or any other medications containing bupropion hydrochloride. The dosage recommendation is 150mg per tablet, to be taken once daily or as directed by a physician. It also mentions storage instructions and contact information for Cambor Pharmaceutical.*

FDA Label Image

Bupropion300mg30scount (Bupropion300mg30scount)

This is a description of a medication called Bupropion Hydrochloride Extended-Release Tablets. It contains 300 mg of bupropion hydrochloride, and the usual dosage is one tablet daily or as directed by a physician. It is advised not to use this medication in combination with ZYBAN® or any other medicines containing bupropion hydrochloride. A warning is provided to keep the medication out of the reach of children. For more information on dosages and storage instructions, refer to the prescribing information. The medication guide can be found at http://camberpharma.com/medication-guides.*

FDA Label Image

Bupropionchemicalstructure (Bupropioncamberlogo)

FDA Label Image

Bupropionchemicalstructure (Bupropionchemicalstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.